Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
VBI Vaccines is a biotechnology business based in the US. VBI Vaccines stocks (VBIV.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.85 – a decrease of 1.04% over the previous week. VBI Vaccines employs 190 staff and has a trailing 12-month revenue of around $1.4 million.
National Bank Direct Brokerage
Finder Award
Interactive Brokers
| Latest market close | $2.85 |
|---|---|
| 52-week range | $2.35 - $40.50 |
| 50-day moving average | $4.59 |
| 200-day moving average | $15.49 |
| Wall St. target price | $4.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-14.43 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $2.85 from 2023-06-02
| 1 week (2023-05-26) | -1.04% |
|---|---|
| 1 month (2023-05-04) | 6.34% |
| 3 months (2023-03-03) | 519.57% |
| 6 months (2022-12-02) | 470.00% |
| 1 year (2022-06-03) | 206.45% |
|---|---|
| 2 years (2021-06-04) | -13.11% |
| 3 years (2020-06-04) | 35.71% |
| 5 years (2018-06-04) | 2.94 |
| Revenue TTM | $1.4 million |
|---|---|
| Gross profit TTM | $-10,194,000 |
| Return on assets TTM | -33.11% |
| Return on equity TTM | -137.24% |
| Profit margin | 0% |
| Book value | $5.23 |
| Market capitalisation | $24.8 million |
TTM: trailing 12 months
We're not expecting VBI Vaccines to pay a dividend over the next 12 months.
VBI Vaccines's shares were split on a 1:30 basis on 12 April 2023. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your VBI Vaccines shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for VBI Vaccines shares which in turn could have impacted VBI Vaccines's share price.
Over the last 12 months, VBI Vaccines's shares have ranged in value from as little as $2.35 up to $40.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while VBI Vaccines's is 1.8276. This would suggest that VBI Vaccines's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
VBI Vaccines Inc. , a biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. The company also develops VBI-2601, an immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study to treat solid tumors; VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial; and VBI-2501 that is in preclinical trial to treat Zika virus. In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited; GlaxoSmithKline Biologicals S. A.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…Compare some of the best bad credit loans in PEI.
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
